Dr. Dinh serves as COO in Shenox and GBD since 2020.
Dr. Dinh earned his Sc.D in Chemical Engineering from MIT. He is a Fellow of the American Society of Pharmaceutical Scientists, and a Fellow of the American Institute for Medical and Biological Engineering.
Prior to his current position, Dr. Dinh was EVP/CSO of CutisPharma, VP/CSO of Noven, VP of Research and Technology of Emisphere, and other company executives.
Dr. Dinh Led the development and successful commercialization of a number of products on the market, including multiple NDA approved products. He also led the advancement of oral (macromolecule) and dermal delivery technologies to support the development of innovative products from ideation to commercialization.